Our Team

Funding resource: Northern Light VC, Greylock, NEA and other institutional investors

  • Xun Meng, Ph.D. – Chief Executive Officer

Dr. Meng was an inventor of Optical Mapping, a genomics technology being used for mapping complex genomic structures. He founded Abmart more than 10 years ago to industrialize antibody generation and target discovery technologies.

  • Shu-Hui Liu, Ph.D. – Chief Scientific Officer

Dr. Liu has >20 years of biotech/pharmaceutical industry experience focusing on developing biologics-based oncology drugs.  Prior to joining Multitude Therapeutics she was the director of the Tumor Biology group at Pfizer in South San Francisco, California.  She has brought multiple discovery programs to the clinic and is the author/coauthor of over 30 publications and numerous patents.